A pharmaceutical company fined 10,000 yuan for producing and selling unqualified pharmaceutical packaging materials

On March 24, the Shandong Provincial Food and Drug Administration issued a notice on the administrative penalty information announcement of Shandong Shipuler Bio-Pharmaceutical Co.

Party: Shandong Shipuler Bio-Pharmaceutical Co.

Main illegal facts:

After inspection by the Jinan Pharmaceutical Packaging Material Inspection Center of the State Food and Drug Administration in accordance with the national standards for pharmaceutical packaging materials, the oral liquid medicinal high-density polyethylene bottle (batch number: 19081301) produced by your company does not meet the standard requirements.

Your company’s production and sales of high-density polyethylene bottles for oral liquids that do not meet the national standards for pharmaceutical packaging materials violated Article 52, paragraph 1, of the "Pharmaceutical Administration Law of the People's Republic of China" (amended in 2015).

The content and basis of administrative punishment:

According to the provisions of Article 64 Paragraph 2 of the "Administrative Measures for Packaging Materials and Containers in Direct Contact with Drugs", supervise and process 669,630 sets of oral liquid medicinal high-density polyethylene bottles (batch number: 19081301) produced by your company, and provide you with The company imposed a fine of 10,000 yuan.